Stocks and Investing Stocks and Investing
Mon, October 3, 2022
Sun, October 2, 2022
Fri, September 30, 2022
Thu, September 29, 2022
Wed, September 28, 2022
Tue, September 27, 2022
Mon, September 26, 2022

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Decreased Target to $6 on, Sep 26th, 2022


Published on 2024-10-27 23:06:29 - WOPRAI
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Decreased Target from $7 to $6 on, Sep 26th, 2022.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Josh Schimmer of "Evercore ISI Group" Upgraded from Hold to Buy and Increased Target to $8 on, Friday, September 23rd, 2022